Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon ; volume:12 ; number:1 ; day:10 ; month:12 ; year:2019 ; pages:1-11 ; date:12.2019
Parasites & vectors ; 12, Heft 1 (10.12.2019), 1-11, 12.2019
- Creator
-
Dejon-Agobé, Jean Claude
Edoa, Jean Ronald
Honkpehedji, Yabo Josiane
Zinsou, Jeannot Fréjus
Adégbitè, Bayodé Roméo
Ngwese, Mirabeau Mbong
Mangaboula, Ance
Lell, Bertrand
Grobusch, Martin Peter
Mordmüller, Benjamin
Adegnika, Ayôla Akim
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13071-019-3836-6
- URN
-
urn:nbn:de:101:1-2020040504402516384215
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dejon-Agobé, Jean Claude
- Edoa, Jean Ronald
- Honkpehedji, Yabo Josiane
- Zinsou, Jeannot Fréjus
- Adégbitè, Bayodé Roméo
- Ngwese, Mirabeau Mbong
- Mangaboula, Ance
- Lell, Bertrand
- Grobusch, Martin Peter
- Mordmüller, Benjamin
- Adegnika, Ayôla Akim
- SpringerLink (Online service)
Other Objects (12)
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Haematological changes in Schistosoma haematobium infections in school children in Gabon
Treatment and diagnosis of Loa loa and Schistosoma haematobium infections in Gabon
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa
Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Haematological changes in Schistosoma haematobium infections in school children in Gabon
Treatment and diagnosis of Loa loa and Schistosoma haematobium infections in Gabon
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa
Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
Safety and Efficacy of Praziquantel in Pregnant Women Infected with Schistosoma haematobium in Lambaréné, Gabon
Haematological changes in Schistosoma haematobium infections in school children in Gabon
Treatment and diagnosis of Loa loa and Schistosoma haematobium infections in Gabon
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa
Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa
CRISPR-assisted test for Schistosoma haematobium
In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children
Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon